These include: Corticosteroid nasal spray. This initial treatment for nasal polyps aims to reduce the size or eliminate the ...

AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...

Tezepelumab was linked to significantly reduced nasal polyp size and nasal congestion vs placebo in adults with severe CRSwNP.

In this randomized controlled trial, among patients with severe, uncontrolled chronic rhinosinusitis with nasal polyps, tezepelumab more effectively reduced nasal polyp size and sinonasal symptoms ...

The following is a summary of "Real-world comparison of T2-biologics effectiveness in severe allergic asthma with nasal polyps,” published in the March 2025 issue of Lung Cancer by Tiotiu et al.

In the treatment group, 70.9% had prior nasal polyp surgery, with a mean of 7.71 years since the most recent surgery. In the placebo group, 71.7% had prior nasal polyp surgery, with a mean of 7.68 ...

Bucks County specialty pharmaceutical company Optinose first started exploring mergers and licensing deals in early 2022.

Sanofi and Regeneron's fast-growing immunology drug Dupixent is on course for a third indication in Europe after being recommended for approval as a treatment for people with nasal polyps.

A new CT-scan-based risk score facilitates the identification of patients at risk of revision endoscopic sinus surgery due to ...

Roshni Naik, MD, allergist at Mount Sinai Health System, discusses the history of present illness for a case of severe asthma with nasal polyps: "Patient is a 45 year-old male with a past medical ...